Recognizing the enormous risks posed by the unregulated over-the-counter (OTC) market, the EU has attempted through EMIR to standardize the clearing of derivatives contracts through central counterparties (CCPs) and to impose collateralized settlement of a large part of OTC trading. The progressive implementation of the clearing obligation has shed light on complex and opaque OTC derivatives markets by simplifying the network of counterparties and has reduced their overall systemic risk by independently evaluating counterparty credit risk and ensuring proper collateralization.
Since entering into force in 2012, EMIR has been reviewed thrice. The first targeted revision of EMIR entered into force in June 2019. The revision mainly contained amendments aiming at ensuring the sound functioning of the regulation and bringing regulatory relief to smaller market participants on reporting and clearing. It notably introduced a minimum threshold for the clearing obligation to provide relief to small financial counterparties.
The second tranche of the review of the EMIR framework was completed in 2020 and relates to the CCP supervision, dealing with both the supervision of EU CCPs and with the authorization and recognition requirements of third-country CCPs. According to the new framework, the ESMA CCP Supervisory Committee is responsible for the recognition and supervision of third-country CCPs based on their systemic importance for the EU. In September 2020, the European Commission announced a time-limited and conditional equivalence for UK CCPs to avoid market disruption after the end of the Brexit transition period, while calling on the industry to reduce their exposures and reliance on UK CCPs that are systemically important for the EU. The European Commission extended the equivalence decision in the meantime until June 2028.
Meanwhile, the third review process resulted in EMIR 3.0, which entered into force in December 2024, with the aim to mitigate excessive exposure to third-country CCPs and improve efficiency and the attractiveness of the EU’s clearing markets. A key change under EMIR 3.0 is the active account requirement, mandating financial and non-financial counterparties, which fall under the clearing obligation and exceed the clearing threshold in systemically relevant interest rate derivatives, to hold active accounts at EU CCPs for clearing a representative portion of those derivatives. Measures to increase the attractiveness of and access to clearing in the EU include streamlined regulatory approval procedures for CCP services and risk models, enhanced CCP admission requirements, and exemptions from UCITS and MMF counterparty limits for centrally cleared derivative transactions. Overhauled anti-procyclicality and margin transparency requirements aim to enhance market preparedness for stress events. These and other aspects of EMIR 3.0 are subject to review clauses through 2029, potentially leading to further amendments of EMIR.